Bristol-Myers Squibb Company (NYSE: BMY) today announced that the company’s Board of Directors has appointed Giovanni Caforio, M.D. as chairman ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE